Incyte's Other Operating Expenses changed N/A to $242.3 million in Q2 2025 from the same period last year, while for Sep 2025 it was $411.5 million, marking a year-over-year increase of 17954.37%. This contributed to the annual value of $330.8 million for FY2024, which is 1558.46% up from last year.
Per Incyte's latest filing, its Other Operating Expenses stood at $242.3 million for Q2 2025.
In the past 5 years, Incyte's Other Operating Expenses registered a high of $242.3 million during Q2 2025, and its lowest value of $34.5 million during Q3 2022.
Over the past 5 years, Incyte's median Other Operating Expenses value was $60.1 million (recorded in 2023), while the average stood at $74.2 million.
Per our database at Business Quant, Incyte's Other Operating Expenses plummeted by 3363.89% in 2022 and then surged by 7619.85% in 2023.
Incyte's Other Operating Expenses (Quarter) stood at $53.1 million in 2021, then surged by 55.26% to $82.4 million in 2022, then grew by 6.41% to $87.7 million in 2023, then fell by 3.73% to $84.4 million in 2024, then soared by 186.89% to $242.3 million in 2025.
Its Other Operating Expenses was $242.3 million in Q2 2025, compared to $84.8 million in Q1 2025 and $84.4 million in Q4 2024.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value